News

Company News

Preora Diagnostics President & CEO John Hart participates in conference highlighting how impact investing can advance leading-edge technologies under development in Chicago (March 22, 2017). Click to view

Award follows Wall Street Journal recognition as a new technology worth watching. (Nov. 29, 2016) Click to view

Successful optimization study moves company forward toward commercialization of PWS Nanoctyology technology platform. (Sept. 22, 2016) Click to view.

In the first episode of its “Amazing Things” podcast series, the national United for Medical Research coalition featured Northwestern Professor and Preora Chairman Vadim Backman, who explains why PWS Nanocytology is a breakthrough method for detecting cancer earlier than ever. (Sept. 13, 2016) Click to view

Company also participating in RESI and Cavendish conferences in September 2016.
Click here to read the full story.
AdvaMed 2016 Innovation Showcase

The Wall Street Journal (June 26, 2016) highlighted our screening tests as an emerging technology that “could have a big impact on medicine in the coming years.”
Click here to read the full story.
Wall Street Journal Article

In its semi-annual newsletter to investors, the Illinois Biotechnology Industry Organization profiled Preora as a company to watch (excerpt from Feb. 2016 issue)
Click here to read the full story.
iBIO Newsletter

Dr. Backman joins Nobel Laureate and other medical experts for prestigious panel discussion. Click to view.

The highly respected and industry-leading Start-up magazine profiled Preora Diagnostics in its September 2015 issue.
Click here to read the full story.
Start-up Profile

Preora President and CEO John W. Hart will participate in the prestigious “Innovation Showcase” at AdvaMed 2015 on October 7.
Click here to read the full story.
Preora to Present at AdvaMed_09.10.15

See All: Company News

Industry/Scientific News

According to the American Cancer Society, there has been a sharp increase of colorectal cancer in adults as young as their 20s and 30s (New York Times, March 16, 2017). Click to view

According to findings from American Cancer Society researchers, very few people who could benefit from lung cancer screening – mostly current and former smokers – are actually getting the tests.  (Feb. 2, 2017) Click to view.

Bloomberg News reports that Merck is setting the pace in immunotherapy to fight lung tumors. (Oct. 9, 2016). Click to view.

The Chicago Tribune (Aug. 22, 2016) covered the ongoing debate regarding the pros and cons of the PSA screening test.
Click here to read the full story:
Chicago Tribune

Stanford University researchers observed that computers had an edge over pathologists classifying tumors (August 2016)
Click here to read the full story.
Stanford University

According to USC research published in the medical journal Thorax, survival of patients in areas with high regional pollution was about three years shorter than for those in areas with lower levels of pollution. (Aug. 5, 2016) Click to view.

According to Grand View Research, lung cancer-specific biomarkers will fuel the grown of the diagnostic market (June 2016)
Click here to read the full story.
Grand View Research

The Chicago Tribune profiled a 37-year-old woman representative of the growing number of nonsmokers who develop lung cancer. (Jan. 2016)
Click here to read the full story.
Chicago Tribune Article

See All: Industry/Scientific News

Subscribe

Enter your email address to subscribe to this news section and receive notifications of new posts by email.

News Archives